Why would anyone 'want' to attend the AVCN conferenceat the MaRs building in the first place WHEN it is only open to medical practitioners and researchers.
The MaRs building in Toronto is home to Johnson & Johnson (JLABS) where they have been doing cannabis based research and AVCN, according to Keith Strachan comment at end of CC quarters ago, a JLABS "spin off".
Well if J & J has AVCN as a cannabis based spin off then who does Pfizer have?
It's all blue and rock hard.